This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1982 Mar 1;49(5):835-9.

doi: 10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co;2-z.

Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study

B L Tranum, B McDonald, T Thigpen, C Vaughn, H Wilson, T Maloney, J Costanzi, J Bickers, N G el Mawli, R Palmer, B Hoogstraten, L Heilburn, S Rasmusen

PMID: 7037152
DOI: 10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co;2-z

Clinical Trial

Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study

B L Tranum et al. Cancer. 1982.

. 1982 Mar 1;49(5):835-9.

doi: 10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co;2-z.

Authors

B L Tranum, B McDonald, T Thigpen, C Vaughn, H Wilson, T Maloney, J Costanzi, J Bickers, N G el Mawli, R Palmer, B Hoogstraten, L Heilburn, S Rasmusen

PMID: 7037152
DOI: 10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co;2-z

No abstract available

PubMed Disclaimer

Similar articles

Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).
Carmo-Pereira J, Costa FO, Henriques E. Carmo-Pereira J, et al. Cancer. 1981 Oct 1;48(7):1517-21. doi: 10.1002/1097-0142(19811001)48:7<1517::aid-cncr2820480707>3.0.co;2-8. Cancer. 1981. PMID: 7026020 Clinical Trial.
Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
Tormey D, Gelman R, Falkson G. Tormey D, et al. Am J Clin Oncol. 1983 Feb;6(1):1-18. Am J Clin Oncol. 1983. PMID: 6340458 Clinical Trial. No abstract available.
Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study.
Carmo-Pereira J, Costa FO, Henriques E. Carmo-Pereira J, et al. Eur J Cancer (1965). 1980 Dec;16(12):1621-5. doi: 10.1016/0014-2964(80)90037-7. Eur J Cancer (1965). 1980. PMID: 7014228 Clinical Trial. No abstract available.
Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
Cowan K, Lippman M. Cowan K, et al. Arch Intern Med. 1981 Jul;141(8):1055-9. Arch Intern Med. 1981. PMID: 7018440 Review. No abstract available.
Chemotherapy for breast cancer.
Sarg MJ Jr. Sarg MJ Jr. J Reprod Med. 1979 Jul;23(1):3-11. J Reprod Med. 1979. PMID: 226698 Review. No abstract available.

See all similar articles

Cited by

Chemotherapy of breast cancer.
Perlow LS, Holland JF. Perlow LS, et al. Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139. Med Oncol Tumor Pharmacother. 1984. PMID: 6400037 Review.
Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.
Lopez M, Vici P, Carpano S, Natali M, Ganzina F, Conti EM, Di Lauro L. Lopez M, et al. J Cancer Res Clin Oncol. 1991;117(1):61-4. doi: 10.1007/BF01613198. J Cancer Res Clin Oncol. 1991. PMID: 1997473 Free PMC article. Clinical Trial.
Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study.
Kolarić K, Potrebica V, Vukas D, Mechl Z, Sopkova B. Kolarić K, et al. J Cancer Res Clin Oncol. 1988;114(3):301-5. doi: 10.1007/BF00405838. J Cancer Res Clin Oncol. 1988. PMID: 3164312 Free PMC article.
Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.
Butters DJ, Ghersi D, Wilcken N, Kirk SJ, Mallon PT. Butters DJ, et al. Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003368. doi: 10.1002/14651858.CD003368.pub3. Cochrane Database Syst Rev. 2010. PMID: 21069675 Free PMC article.
Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancer.
Suzuki Y, Ogiya R, Oshitanai R, Terao M, Terada M, Morioka T, Tsuda B, Niikura N, Okamura T, Saito Y, Tokuda Y. Suzuki Y, et al. Int J Clin Oncol. 2014 Apr;19(2):274-9. doi: 10.1007/s10147-013-0547-4. Epub 2013 Apr 5. Int J Clin Oncol. 2014. PMID: 23558559

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Medical
- MedlinePlus Health Information